期刊文献+

PDR玻璃体切割术后继发新生血管性青光眼的再次手术分析 被引量:2

Analysis of secondary surgery for neovascular glaucoma after vitrectomy in PDR
下载PDF
导出
摘要 目的:探讨增殖性糖尿病视网膜病变(proliferative diabetic retinopathy,PDR)玻璃体切割术后继发新生血管性青光眼(neovascular glaucoma,NVG)的影响因素及再次手术疗效。方法:回顾性分析2009-10/2012-12因PDR玻璃体切割术后继发NVG行再次玻璃体手术联合激光光凝治疗的7例7眼患者临床资料。结果:患者7例首次术前眼压11.21±4.22mmHg。术中激光622~1124点,患者均联合白内障摘除术,5例植入人工晶状体。术后2mo内眼压10.11±3.62mmHg。随访中7例术眼炎症加重,2例玻璃体积血未完全吸收,5例复发玻璃体积血,5例血糖控制欠佳、2例血压控制欠佳。7例均发生NVG。再次手术前眼压41.13±7.76mmHg,术后眼压5例正常,1例睫状体光凝术后正常,1例失访,眼压未控制。结论:首次术中联合行晶状体手术、激光斑不足、术后出血不吸收及再次出血、眼内炎症及全身因素均可能是PDR术后NVG形成危险因素。再次玻璃体手术联合充分视网膜光凝可有效控制PDR术后NVG的眼压。 AIM: To investigate risk factors and efficacy of reoperation for neovascular glaucoma( NVG) secondary to vitrectomy in proliferative diabetic retinopathy( PDR).METHODS: Seven cases( 7 eyes) from October,2009 to December,2012 were analyzed retrospectively. All the patients had NVG after the primary vitrectomy for PDR and were performed secondary vitrectomy combined with laser photocoagulation.RESULTS: The mean intraocular pressure( IOP) was( 11.21±4.22) mmHg before primary surgery. The number of laser spots ranged from 622 to 1124 during the first vitrectomy. Cataract extraction was performed in all 7cases and intraocular lens was implanted in 5 cases. The mean IOP was( 10.11±3.62) mmHg during 2mo after the primary surgery. During follow- up,all the patients had significantly progressive intraocular inflammation.Vitreous hemorrhage was not absorbed completely in 2cases and recurrent vitreous hemorrhage occurred in the other 5 cases. Five cases had poor glycemic control and the other 2 cases had bad blood pressure control. NVG occurred in all 7cases. The mean IOP was( 41. 13± 7. 76)mmHg before the secondary surgery. After the secondary surgery,the IOP were under control in 5 cases. For theother 2 cases,the IOP was controlled in one case by transscleral cyclophotocoagulation,another one was lost in follow-up with uncontrolled IOP.CONCLUSION: Primary vitrectomy combined with lens extraction, insufficient laser speckle, unabsorbed and recurrent vitreous hemorrhage,intraocular inflammation and systemic condition may be the risk factors associated with the occurrent of NVG after vitrectomy in PDR.Secondary vitrectomy combined with sufficient retinal photocoagulation is efficiency for NVG after vitrectomy for the PDR.
作者 刘静 韩泉洪
出处 《国际眼科杂志》 CAS 2014年第9期1694-1696,共3页 International Eye Science
关键词 糖尿病视网膜病变 玻璃体切割术 新生血管性青光眼 再次手术 diabetic retinopathy vitrectomy neovascular glaucoma secondary surgery
  • 相关文献

参考文献17

  • 1Mohamed Q,Gillies MC,Wong TY.Management of diabetic retinopathy: asystematic review.JAMA 2007; 298(8):902-916.
  • 2Scanlon PH.Why do patients still require surgery for the late complications of proliferative diabetic retinopathy? Eye 2010; 24(3):435-440.
  • 3Ozone D,Hirano Y,Ueda J,et al.Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.Ophthalmologica 2011; 226(2): 76-80.
  • 4王桂云,左玲,刘茂雄.增殖型糖尿病视网膜病变玻璃体切割手术并发症及发生因素分析[J].中国实用眼科杂志,2005,23(7):682-684. 被引量:10
  • 5Diabetic Retinopathy Vitrectomy Study Research Group.Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy.Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy study report 5.Arch Ophthalmol 1990; 108(7):958-964.
  • 6高立新,张薇.增殖性糖尿病视网膜病变的玻璃体手术治疗[J].中国实用眼科杂志,2005,23(1):55-58. 被引量:37
  • 7akabayashi Y,Usui Y,Okunuki Y,et al.Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.Invest Ophthalmol Vis Sci 2012; 53(10):6403-6410.
  • 8张蕙蓉.眼微循环及相关疾病[M].北京:北京医科大学、中国协和医科大学联合出版社,1993.190-194.
  • 9Rice TA,Michels RG,Magnire MG,et al.The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabtic retinopathy.Am J Ophthalmol 1983; 95(1):1-11.
  • 10Poline LS,Christianson DJ,Escoffery RF,et al.Neovascular glaucoma after intracapsular and extracapsular cataract extraction in diabetic patients.Am J Ophthalmol 1985; 100(5): 637-643.

二级参考文献30

  • 1黎晓新,吕永顺,李立新,魏丽媛.增殖性糖尿病性视网膜病变的激光治疗量与疗效[J].眼科,1992,1(1):12-14. 被引量:6
  • 2张承芬,赵强.增殖前期与增殖期糖尿病性视网膜病变的激光治疗[J].中华眼科杂志,1989,25(6):329-332. 被引量:39
  • 3刘豪杰,周明,邵彦.激光光凝治疗增殖期糖尿病视网膜病变[J].中国实用眼科杂志,2006,24(2):167-168. 被引量:19
  • 4郭智勇,王润生,张惠霞.半导体激光治疗糖尿病视网膜病变138例[J].国际眼科杂志,2006,6(3):714-715. 被引量:3
  • 5吕永顺 鲍永珍 等.氩激光视网膜光凝治疗增殖型糖尿病视网膜病变的疗效[J].中华眼底病杂志,1995,12:114-114.
  • 6Diabetic Retinopathy Vitrectomy Study Research Group:Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy:two—year results of a randomized trial.DRVS Report 2.Arch Ophthalmol,1985,103:1644.
  • 7Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision - - DRVS Report 3. Ophthalmology, 1988, 95:1307.
  • 8Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy-DRVS Report 5. Arch Ophthalmol, 1990, 108:958.
  • 9McLeod D. Entry site neovascularisation after diabetic vitrectomy.BrJOphthalmol, 2000, 84:810.
  • 10Lewis H, Abrams GW, Williams GA. Anterior hyaloidal fibrovoscular proliferation after diabetic vitrectomy. Am J Ophthalmol, 1987, 104:607.

共引文献139

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部